Treatment Outcomes of Clopidogrel in Patients With ACS and Diabetes Undergoing PCI-Analysis of Beijing Municipal Medical Insurance Database

Treatment Outcomes of Clopidogrel in Patients With ACS and Diabetes Undergoing PCI-Analysis of Beijing Municipal Medical Insurance Database

Background and AimsSeveral clinical trials have proved the efficacy of clopidogrel treatment for patients with percutaneous coronary intervention. There are few large-scale studies to identify the mortality associated with different durations of treatment of clopidogrel in patients with diabetes and...

Full description

Bibliographic Details
Main Authors: Weihao Wang, Xiaoxia Wang, Lina Zhang, Jie Zhang, Fuli Man, Qi Pan, Lixin Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Endocrinology
Subjects:
clopidogrel
mortality
diabetes
PCI
medical insurance database
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.713849/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.713849/full

Similar Items